Stock listing

Helsinki:REG1V Revenio Group Oyj Osake

Home listing (Helsinki) of Revenio Group Oyj

Follow Revenio Group Oyj into a list and get an email when it puts out news.

Share price · OMXHEX:REG1V

€11.04 EUR -0.46 (-4.0%)

Close on Oct 15, 2026

Revenio Group Oyj logo
Ticker
Helsinki:REG1V
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Helsinki
Currency
EUR

What changed lately

Calls

Replays

  • Revenio Group (Helsinki:REG1V) Q2 2026 Earnings Call

    Tue, Sep 08, 2026 · 3:00 AM ET

    Watch Transcript

  • Revenio Group (Helsinki:REG1V) Q1 2026 Earnings Call

    Tue, Apr 28, 2026 · 8:00 AM ET

    Watch Transcript

  • Revenio Group (Helsinki:REG1V) Q4 2025 Earnings Call

    Wed, Feb 11, 2026 · 3:00 AM ET

    Watch Transcript

Latest news

Revenio Group: The Finnish Financial Supervisory Authority has approved the Finnish language prospectus in relation to Revenio Group Corporation's rights offering

Sep 25, 2026

INSIDE INFORMATION: Revenio Group Corporation announces the terms and conditions of its fully underwritten rights offering of approximately EUR 80 million

Sep 21, 2026

Revenio updates its strategy for 2027–2029 and provides new financial targets for the strategy period

Sep 15, 2026

Composition of Revenio's Shareholders' Nomination Board

Sep 14, 2026

Revenio Group Corporation: Half-Year Report January 1 - June 30, 2026

Sep 8, 2026

Half-year report January-June 2026 to be published on September 8, 2026

Aug 27, 2026

Invitation to Revenio Group's Capital Markets Day 2026

Aug 20, 2026

Invitation to Revenio Group’s Capital Markets Day 2026

Aug 20, 2026

Revenio Oyj iCare DRSplus included in FDA-cleared AI solution for diabetic retinopathy screening

Aug 17, 2026

Jukka Kainulainen starts as Revenio CFO on August 24, 2026

Aug 12, 2026

All Revenio Group Oyj news

Financings

  • Rights offering of offer shares

    Sep 25, 2026 · US$91.18M

    Update: about €80M · €6.19 a share · Nordea Bank Abp

    Dealers: Nordea Bank Abp (lead)

    Buyers: William Demant Invest A/S (together with Caravelle Capital SAS and other Visionix sellers, committed to subscribe for an aggregate of approximately 31.4 percent of the offer shares); Caravelle Capital SAS (together with William Demant Invest A/S and other Visionix sellers, committed to subscribe for an aggregate of approximately 31.4 percent of the offer shares)

    Use of proceeds: Repay the outstanding EUR 80 million bridge-to-equity facility related to the Visionix acquisition

    Announced Sep 21, 2026 · Update Sep 25, 2026

Read by 6ix AI from the company's releases

Decks

Revenio Group Oyj on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
27 in the last 12 months · 27 in all · newest Sep 25, 2026 · oldest 2026
Calls
21 calls with a replay · 21 with a transcript · latest Sep 8, 2026
Decks
23 decks · latest Sep 8, 2026

Where Revenio Group Oyj is listed

ListingExchangeCountryCurrency
Helsinki:REG1V · Home listing · This pageHelsinkiFinlandEUR
gettex:R0VgettexGermanyEUR
LSE:0KFHLSEUnited KingdomEUR
LS Exchange:805985LS ExchangeGermanyEUR
Aquis:REG1VHAquisUnited KingdomEUR
Lang & Schwarz:805985Lang & SchwarzGermanyEUR
OTC:REVXFOTCUnited StatesUSD
Tradegate:R0VTradegateGermanyEUR
Munich:R0VMunichGermanyEUR
Aquis:REG1VHAquisUnited KingdomEUR
Stuttgart:R0VStuttgartGermanyEUR
Turquoise:REG1VHTurquoiseUnited KingdomEUR
Dusseldorf:R0VDusseldorfGermanyEUR
Frankfurt:R0VFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Revenio Group Oyj.